LAG3 and cancer: Also, PD-1 blockade combined with other checkpoint blockades, such as Tim-3, LAG-3, or TIGIT, significantly reverses T cell dysfunction and enhances antitumor immunity in patients with cancer, compared to individual checkpoint blockade (25, 26, 178, 179).